These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9766764

  • 1. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.
    Smith WT, Londborg PD, Glaudin V, Painter JR.
    Am J Psychiatry; 1998 Oct; 155(10):1339-45. PubMed ID: 9766764
    [Abstract] [Full Text] [Related]

  • 2. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH.
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [Abstract] [Full Text] [Related]

  • 3. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
    Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G.
    Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L, Berk M, Vorster M.
    J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
    Schmidt ME, Fava M, Robinson JM, Judge R.
    J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738
    [Abstract] [Full Text] [Related]

  • 11. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J.
    J Clin Psychiatry; 1998 Nov; 59 Suppl 14():8-10. PubMed ID: 9818624
    [Abstract] [Full Text] [Related]

  • 12. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
    Smith WT, Londborg PD, Glaudin V, Painter JR, Summit Research Network.
    J Affect Disord; 2002 Aug; 70(3):251-9. PubMed ID: 12128237
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [Abstract] [Full Text] [Related]

  • 14. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH, Salinas E.
    J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB, Stahl SM, Hertzman M, Harrison WM.
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J.
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
    Suri RA, Altshuler LL, Rasgon NL, Calcagno JL, Frye MA, Gitlin MJ, Hwang S, Zuckerbrow-Miller J.
    J Clin Psychiatry; 2000 Dec; 61(12):942-6. PubMed ID: 11206600
    [Abstract] [Full Text] [Related]

  • 19. Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder.
    Agid O, Shalev AY, Lerer B.
    J Clin Psychiatry; 2001 Mar; 62(3):169-73. PubMed ID: 11305702
    [Abstract] [Full Text] [Related]

  • 20. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
    McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF.
    Am J Psychiatry; 2000 Mar; 157(3):344-50. PubMed ID: 10698808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.